Avidity Partners Management LP Q1 2023 Filing
Filed May 15, 2023
Portfolio Value
$3.0T
Holdings
83
Report Date
Q1 2023
Filing Type
13F-HR
All Holdings (83 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ARVNARVINAS INC | 4,273,900 | $116.8B | 3.88% | |
| 2 | SGRYSURGERY PARTNERS INC | 3,355,900 | $115.7B | 3.84% | |
| 3 | BUWABIO RAD LABS INC | 221,500 | $106.1B | 3.52% | |
| 4 | ARGXARGENX SE | 280,700 | $104.6B | 3.47% | |
| 5 | JAZZJAZZ PHARMACEUTICALS PLC | 677,900 | $99.2B | 3.29% | |
| 6 | REGNREGENERON PHARMACEUTICALS | 119,100 | $97.9B | 3.25% | |
| 7 | AKROAKERO THERAPEUTICS INC | 2,447,000 | $93.6B | 3.11% | |
| 8 | THCTENET HEALTHCARE CORP | 1,472,000 | $87.5B | 2.90% | |
| 9 | RAREULTRAGENYX PHARMACEUTICAL IN | 2,126,900 | $85.3B | 2.83% | |
| 10 | UHSUNIVERSAL HLTH SVCS INC | 670,000 | $85.2B | 2.83% | |
| 11 | ACHCACADIA HEALTHCARE COMPANY IN | 1,165,300 | $84.2B | 2.79% | |
| 12 | NBIXNEUROCRINE BIOSCIENCES INC | 815,700 | $82.6B | 2.74% | |
| 13 | SNDXSYNDAX PHARMACEUTICALS INC | 3,865,300 | $81.6B | 2.71% | |
| 14 | KRTXKARUNA THERAPEUTICS INC | 403,800 | $73.3B | 2.43% | |
| 15 | BDXBECTON DICKINSON & CO | 288,000 | $71.3B | 2.37% | |
| 16 | PLRXPLIANT THERAPEUTICS INC | 2,665,000 | $70.9B | 2.35% | |
| 17 | ZTSZOETIS INC | 407,500 | $67.8B | 2.25% | |
| 18 | VTYXVENTYX BIOSCIENCES INC | 1,917,800 | $64.2B | 2.13% | |
| 19 | MRKMERCK & CO INC | 600,000 | $63.8B | 2.12% | |
| 20 | SRPTSAREPTA THERAPEUTICS INC | 416,000 | $57.3B | 1.90% | |
| 21 | LEGNLEGEND BIOTECH CORP | 1,120,500 | $54.0B | 1.79% | |
| 22 | PRTAPROTHENA CORP PLC | 1,068,200 | $51.8B | 1.72% | |
| 23 | IDYAIDEAYA BIOSCIENCES INC | 3,673,400 | $50.4B | 1.67% | |
| 24 | ZNTLZENTALIS PHARMACEUTICALS INC | 2,929,300 | $50.4B | 1.67% | |
| 25 | OPHTEURIVERIC BIO INC | 1,869,200 | $45.5B | 1.51% | |
| 26 | ARWRARROWHEAD PHARMACEUTICALS IN | 1,741,300 | $44.2B | 1.47% | |
| 27 | PACBPACIFIC BIOSCIENCES CALIF IN | 3,812,600 | $44.1B | 1.47% | |
| 28 | BSXBOSTON SCIENTIFIC CORP | 850,000 | $42.5B | 1.41% | |
| 29 | AXSMAXSOME THERAPEUTICS INC | 619,200 | $38.2B | 1.27% | |
| 30 | VIRVIR BIOTECHNOLOGY INC | 1,640,200 | $38.2B | 1.27% | |
| 31 | IMCRIMMUNOCORE HLDGS PLC | 769,800 | $38.1B | 1.26% | |
| 32 | KPTIEURKARYOPHARM THERAPEUTICS INC | 9,633,911 | $37.5B | 1.24% | |
| 33 | ABTABBOTT LABS | 354,000 | $35.8B | 1.19% | |
| 34 | BIIBBIOGEN INC | 128,800 | $35.8B | 1.19% | |
| 35 | BLUBELLUS HEALTH INC NEW | 4,553,577 | $32.8B | 1.09% | |
| 36 | ICLRICON PLC | 142,900 | $30.5B | 1.01% | |
| 37 | BMRNBIOMARIN PHARMACEUTICAL INC | 300,575 | $29.2B | 0.97% | |
| 38 | RVMDREVOLUTION MEDICINES INC | 1,344,800 | $29.1B | 0.97% | |
| 39 | ETNBGBP89BIO INC | 1,842,976 | $28.1B | 0.93% | |
| 40 | AMLXAMYLYX PHARMACEUTICALS INC | 900,000 | $26.4B | 0.88% | |
| 41 | CVACCUREVAC N V | 3,550,000 | $24.7B | 0.82% | |
| 42 | AVTRAVANTOR INC | 1,125,000 | $23.8B | 0.79% | |
| 43 | NSTGEURNANOSTRING TECHNOLOGIES INC | 2,217,000 | $21.9B | 0.73% | |
| 44 | —FUSION PHARMACEUTICALS INC | 5,700,000 | $21.5B | 0.71% | |
| 45 | RCKTROCKET PHARMACEUTICALS INC | 1,244,400 | $21.3B | 0.71% | |
| 46 | KZRKEZAR LIFE SCIENCES INC | 6,519,400 | $20.4B | 0.68% | |
| 47 | BHVNBIOHAVEN LTD | 1,487,200 | $20.3B | 0.67% | |
| 48 | ABGAMERISOURCEBERGEN CORP | 126,600 | $20.3B | 0.67% | |
| 49 | MLYSMINERALYS THERAPEUTICS INC | 1,263,800 | $19.8B | 0.66% | |
| 50 | VERVVERVE THERAPEUTICS INC | 1,351,700 | $19.5B | 0.65% | |
| 51 | RNAAVIDITY BIOSCIENCES INC | 1,265,545 | $19.4B | 0.64% | |
| 52 | PCVXVAXCYTE INC | 510,000 | $19.1B | 0.63% | |
| 53 | ARQTARCUTIS BIOTHERAPEUTICS INC | 1,628,500 | $17.9B | 0.59% | |
| 54 | VRNAVERONA PHARMA PLC | 878,800 | $17.6B | 0.59% | |
| 55 | —POINT BIOPHARMA GLOBAL INC | 2,411,600 | $17.5B | 0.58% | |
| 56 | DC4DEXCOM INC | 148,000 | $17.2B | 0.57% | |
| 57 | BBIOBRIDGEBIO PHARMA INC | 1,000,000 | $16.6B | 0.55% | |
| 58 | IMVTIMMUNOVANT INC | 1,043,000 | $16.2B | 0.54% | |
| 59 | NTLAINTELLIA THERAPEUTICS INC | 417,000 | $15.5B | 0.52% | |
| 60 | CRBUCARIBOU BIOSCIENCES INC | 2,758,600 | $14.6B | 0.49% | |
| 61 | PHATPHATHOM PHARMACEUTICALS INC | 2,048,600 | $14.6B | 0.49% | |
| 62 | —MERSANA THERAPEUTICS INC | 3,433,233 | $14.1B | 0.47% | |
| 63 | NTRANATERA INC | 249,900 | $13.9B | 0.46% | |
| 64 | TWSTTWIST BIOSCIENCE CORP | 819,000 | $12.4B | 0.41% | |
| 65 | COLLCOLLEGIUM PHARMACEUTICAL INC | 385,500 | $9.2B | 0.31% | |
| 66 | CYTKCYTOKINETICS INC | 252,000 | $8.9B | 0.29% | |
| 67 | NVLSEURALPINE IMMUNE SCIENCES INC | 989,500 | $7.6B | 0.25% | |
| 68 | —KINNATE BIOPHARMA INC | 1,160,000 | $7.3B | 0.24% | |
| 69 | ANTXAN2 THERAPEUTICS INC | 723,200 | $7.1B | 0.24% | |
| 70 | CMPXCOMPASS THERAPEUTICS INC | 1,825,000 | $6.0B | 0.20% | |
| 71 | ALTALTIMMUNE INC | 1,315,200 | $5.6B | 0.18% | |
| 72 | GONGERON CORP | 2,128,000 | $4.6B | 0.15% | |
| 73 | IPSCCENTURY THERAPEUTICS INC | 1,268,100 | $4.4B | 0.15% | |
| 74 | GBYSANGAMO THERAPEUTICS INC | 2,470,000 | $4.3B | 0.14% | |
| 75 | PRAXPRAXIS PRECISION MEDICINES I | 4,281,700 | $3.5B | 0.11% | |
| 76 | CYTCYTEIR THERAPEUTICS INC | 1,764,100 | $3.2B | 0.11% | |
| 77 | SYRSSYROS PHARMACEUTICALS INC | 904,630 | $2.4B | 0.08% | |
| 78 | HYPRHYPERFINE INC | 1,503,754 | $2.2B | 0.07% | |
| 79 | —CAREMAX INC | 755,329 | $2.0B | 0.07% | |
| 80 | BCABBIOATLA INC | 602,500 | $1.6B | 0.05% | |
| 81 | ACIUAC IMMUNE SA | 325,400 | $761.4M | 0.03% | |
| 82 | —REUNION NEUROSCIENCE INC | 151,098 | $104.3M | 0.00% | |
| 83 | NUVB/WSNUVATION BIO INC | 99,999 | $12.0M | 0.00% |